Isolation of deletion and substitution mutants of adenovirus type 5 - PubMed (original) (raw)

Isolation of deletion and substitution mutants of adenovirus type 5

N Jones et al. Cell. 1978 Jan.

No abstract available

PubMed Disclaimer

Similar articles

• Genome structure of adenovirus 12 host range mutants adapted to growth in simian Vero cells.
  Salewski E, Werner G, Opalka B, Schwarz E, Schulte Holthausen H. Salewski E, et al. Intervirology. 1989;30(1):44-51. doi: 10.1159/000150075. Intervirology. 1989. PMID: 2524454
• Deletions and insertions in adenovirus type 12 DNA after viral replication in Vero cells.
  Werner G, zur Hausen H. Werner G, et al. Virology. 1978 May 1;86(1):66-77. doi: 10.1016/0042-6822(78)90008-9. Virology. 1978. PMID: 664232 No abstract available.
• Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells.
  Jones N, Shenk T. Jones N, et al. Cell. 1979 Jul;17(3):683-9. doi: 10.1016/0092-8674(79)90275-7. Cell. 1979. PMID: 476833
• Recombination between adenovirus DNA and the mammalian genome.
  Doerfler W, Jessberger R, Lichtenberg U. Doerfler W, et al. Curr Top Microbiol Immunol. 1989;144:209-16. doi: 10.1007/978-3-642-74578-2_26. Curr Top Microbiol Immunol. 1989. PMID: 2676362 Review. No abstract available.
• [Adenovirus vectors].
  Yamada M. Yamada M. Uirusu. 1986 Jun;36(1):11-21. doi: 10.2222/jsv.36.11. Uirusu. 1986. PMID: 3535238 Review. Japanese. No abstract available.

Cited by

• HBO1/KAT7/MYST2 HAT complex regulates human adenovirus replicative cycle.
  Kamel H, Shete V, Gadamsetty S, Graves D, Bachus S, Akkerman N, Pelka P, Thimmapaya B. Kamel H, et al. Heliyon. 2024 Mar 29;10(7):e28827. doi: 10.1016/j.heliyon.2024.e28827. eCollection 2024 Apr 15. Heliyon. 2024. PMID: 38601626 Free PMC article.
• A Renaissance for Oncolytic Adenoviruses?
  Blanchette P, Teodoro JG. Blanchette P, et al. Viruses. 2023 Jan 26;15(2):358. doi: 10.3390/v15020358. Viruses. 2023. PMID: 36851572 Free PMC article. Review.
• The use of adenoviral vectors in gene therapy and vaccine approaches.
  Araújo NM, Rubio IGS, Toneto NPA, Morale MG, Tamura RE. Araújo NM, et al. Genet Mol Biol. 2022 Oct 7;45(3 Suppl 1):e20220079. doi: 10.1590/1678-4685-GMB-2022-0079. eCollection 2022. Genet Mol Biol. 2022. PMID: 36206378 Free PMC article.
• CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models.
  Puigdelloses M, Garcia-Moure M, Labiano S, Laspidea V, Gonzalez-Huarriz M, Zalacain M, Marrodan L, Martinez-Velez N, De la Nava D, Ausejo I, Hervás-Stubbs S, Herrador G, Chen Z, Hambardzumyan D, Patino Garcia A, Jiang H, Gomez-Manzano C, Fueyo J, Gállego Pérez-Larraya J, Alonso M. Puigdelloses M, et al. J Immunother Cancer. 2021 Jul;9(7):e002644. doi: 10.1136/jitc-2021-002644. J Immunother Cancer. 2021. PMID: 34281988 Free PMC article.
• Effect of adenovirus infection on transgene expression under the adenoviral MLP/TPL and the CMVie promoter/enhancer in CHO cells.
  El-Mogy MA, Abdalla MAK, Misic V, Haj-Ahmad Y. El-Mogy MA, et al. J Genet Eng Biotechnol. 2017 Jun;15(1):211-217. doi: 10.1016/j.jgeb.2017.04.003. Epub 2017 Apr 21. J Genet Eng Biotechnol. 2017. PMID: 30647657 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations